397 related articles for article (PubMed ID: 21894514)
1. Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments.
Scorletti E; Calder PC; Byrne CD
Endocrine; 2011 Dec; 40(3):332-43. PubMed ID: 21894514
[TBL] [Abstract][Full Text] [Related]
2. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.
Byrne CD
Proc Nutr Soc; 2013 Nov; 72(4):412-9. PubMed ID: 23668723
[TBL] [Abstract][Full Text] [Related]
3. Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.
Pacifico L; Nobili V; Anania C; Verdecchia P; Chiesa C
World J Gastroenterol; 2011 Jul; 17(26):3082-91. PubMed ID: 21912450
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
Muzurović E; Mikhailidis DP; Mantzoros C
Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
[TBL] [Abstract][Full Text] [Related]
5. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.
Santos RD; Valenti L; Romeo S
Atherosclerosis; 2019 Mar; 282():110-120. PubMed ID: 30731283
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients.
Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Milic S; Orlic L
Med Hypotheses; 2014 Feb; 82(2):205-8. PubMed ID: 24365277
[TBL] [Abstract][Full Text] [Related]
7. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
[TBL] [Abstract][Full Text] [Related]
8. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
El-Koofy NM; Anwar GM; El-Raziky MS; El-Hennawy AM; El-Mougy FM; El-Karaksy HM; Hassanin FM; Helmy HM
Saudi J Gastroenterol; 2012; 18(1):44-9. PubMed ID: 22249092
[TBL] [Abstract][Full Text] [Related]
9. Does non-alcoholic fatty liver disease (NAFLD) increase cardiovascular risk?
Montecucco F; Mach F
Endocr Metab Immune Disord Drug Targets; 2008 Dec; 8(4):301-7. PubMed ID: 19075784
[TBL] [Abstract][Full Text] [Related]
10. Recent concepts in non-alcoholic fatty liver disease.
Adams LA; Angulo P
Diabet Med; 2005 Sep; 22(9):1129-33. PubMed ID: 16108837
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?
Ahmed MH; Barakat S; Almobarak AO
J Obes; 2012; 2012():483135. PubMed ID: 23320150
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter.
Chiriac S; Stanciu C; Girleanu I; Cojocariu C; Sfarti C; Singeap AM; Cuciureanu T; Huiban L; Muzica CM; Zenovia S; Nastasa R; Trifan A
Can J Gastroenterol Hepatol; 2021; 2021():6696857. PubMed ID: 33505944
[TBL] [Abstract][Full Text] [Related]
13. Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.
Byrne CD
Diabet Med; 2012 Sep; 29(9):1098-107. PubMed ID: 22672330
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome.
Lim S; Taskinen MR; Borén J
Obes Rev; 2019 Apr; 20(4):599-611. PubMed ID: 30589487
[TBL] [Abstract][Full Text] [Related]
15. The role of non-alcoholic fatty liver disease in cardiovascular disease.
Perseghin G
Dig Dis; 2010; 28(1):210-3. PubMed ID: 20460913
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
Dietrich P; Hellerbrand C
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
[TBL] [Abstract][Full Text] [Related]
17. Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.
Byrne CD; Targher G
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1155-61. PubMed ID: 24743428
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders.
Lim S; Oh TJ; Koh KK
Int J Cardiol; 2015 Dec; 201():408-14. PubMed ID: 26310987
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease.
Gaggini M; Morelli M; Buzzigoli E; DeFronzo RA; Bugianesi E; Gastaldelli A
Nutrients; 2013 May; 5(5):1544-60. PubMed ID: 23666091
[TBL] [Abstract][Full Text] [Related]
20. Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and Dysbiosis.
Scorletti E; Byrne CD
Dig Dis; 2016; 34 Suppl 1():11-8. PubMed ID: 27548822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
